health - "national hiv"

The number of people infected with hiv, the virus that causes AIDS, is 40 percent higher than the Centers for Disease Control and Prevention has been reporting each year, according to new figures recently ...

' The AIDS Foundation of Chicago received a nearly $1.4-million federal grant to provide permanent housing for low-income people living with HIV/AIDS. The funding is part of a $19.4-million Department of ...

Less than 1% of the $669 million reported in global prevention spending targets men who have sex with men, according to UNAIDS ...

Hiv/AIDS experts have called for an end to the stigma, discrimination and violence that drive those infected with the disease underground allowing the illness to flourish.

Bruce Roth's name may not be on the tip of many tongues, but his invention has been on more than 26 million in the United States alone. Inventor of Lipitor, the cholesterol-lowering pill that is the world's largest selling drug, Roth is among 25 unsung scientific heroes who are being inducted into an American Chemical Society (ACS) hall of fame called the Heroes of Chemistry.

Nearly 200 struggling souls gathered for a candlelight vigil the other night in a North Philadelphia neighborhood with a simple mantra: One Day at a Time.

Several Seattle organizations are trying to find better ways to help HIV/AIDS patients, especially those who are mentally ill, addicted to drugs or homeless, manage their complex mixtures of medications.

MEXICO CITY—Forecasters say Tropical Storm Iselle has been downgraded to a depression off Mexico's Pacific coast. The U.S. national Hurricane Center in Miami says Iselle's winds have fallen to u...

A new report published by the Stockholm Environment Institute, University of York, in collaboration with Help the Aged, calls on government and public authorities to take action to better protect older people from the future effects of climate change. The report Growing Old in a Changing Climate is the first national report to examine the impact of climate change on an ageing population.

(International AIDS Vaccine Initiative) A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the national AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well-tolerated.